These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 10968438)
1. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438 [TBL] [Abstract][Full Text] [Related]
2. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829 [TBL] [Abstract][Full Text] [Related]
3. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
4. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
5. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Limaye AP Clin Infect Dis; 2002 Oct; 35(7):866-72. PubMed ID: 12228824 [TBL] [Abstract][Full Text] [Related]
6. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients. Limaye AP Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand. Bruminhent J; Rotjanapan P; Watcharananan SP Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524 [TBL] [Abstract][Full Text] [Related]
8. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis. Martin M; Goyette N; Ives J; Boivin G J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805 [TBL] [Abstract][Full Text] [Related]
9. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790 [TBL] [Abstract][Full Text] [Related]
10. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients. Mylonakis E; Kallas WM; Fishman JA Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729 [TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients. Li F; Kenyon KW; Kirby KA; Fishbein DP; Boeckh M; Limaye AP Clin Infect Dis; 2007 Aug; 45(4):439-47. PubMed ID: 17638191 [TBL] [Abstract][Full Text] [Related]
12. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation. West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740 [TBL] [Abstract][Full Text] [Related]
13. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
14. Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients. López-Medrano F; Rueda B; Lizasoain M; Juan RS; Folgueira D; Andrés A; Morales JM; Jiménez C; Meneu JC; Aguado JM Transpl Infect Dis; 2009 Oct; 11(5):400-4. PubMed ID: 19570139 [TBL] [Abstract][Full Text] [Related]
15. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene. Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247 [TBL] [Abstract][Full Text] [Related]
16. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021 [TBL] [Abstract][Full Text] [Related]
17. [Strains of ganciclovir-resistant cytomegalovirus]. Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184 [TBL] [Abstract][Full Text] [Related]
18. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Murray BM; Subramaniam S Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220 [TBL] [Abstract][Full Text] [Related]
19. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Eid AJ; Arthurs SK; Deziel PJ; Wilhelm MP; Razonable RR Clin Transplant; 2008; 22(2):162-70. PubMed ID: 18339135 [TBL] [Abstract][Full Text] [Related]
20. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression. Shah AP; Chen JM; Fridell JA Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]